Medical Devices Startups
6,008 companies tagged Medical Devices, with their investors and founders.
CoNextions Medical develops implantable devices for orthopaedic soft tissue repair, including systems for tendon repair and soft tissue-to-bone fixation intended for use by surgeons. Its implants are designed to replace or improve on conventional suture-based repair methods.
2 investors
Coologics develops a drug-free medical device designed to treat vaginal yeast and bacterial infections through controlled cooling technology. The device targets women seeking non-pharmaceutical relief and clinical cure from recurrent infections.
2 investors
CoolSculpting offers FDA-cleared body-contouring procedures that use controlled cooling to reduce visible fat bulges in areas such as the chin, abdomen, thighs, and flanks, along with the CoolTone device for muscle strengthening and toning. The procedures are administered under medical supervision and are marketed to consumers seeking non-surgical fat reduction and muscle stimulation rather than weight loss.
2 investors
CoolStat is an investigational medical device that delivers dry air through the nasal passages to cool patients with fever and other conditions, currently being studied in clinical trials for neurogenic fever, cardiac arrest, and migraine pain management.
2 investors
CoraVie Medical is an early-stage company developing an implantable, ultrasound-based device for continuous, long-term blood pressure monitoring in people with hypertension. The system provides automatic measurement without cuffs or manual logging, aimed at giving physicians more reliable data for earlier intervention.
2 investors
Corcept develops cortisol modulators β molecules that regulate cortisol activity at the glucocorticoid receptor β to treat serious diseases across endocrinology, oncology, metabolism, and neurology. Its FDA-approved drug Korlym (mifepristone) treats hypercortisolism (Cushing syndrome), and the company has over 30 ongoing studies and more than 1,000 discovered proprietary cortisol modulators.
2 investors
Corcym is a medical device company that develops therapies and devices for patient care. The page emphasizes product safety information and customer support for medical device users.
2 investors
Cordio Medical develops medical-grade digital health solutions that use speech signal processing algorithms to help patients monitor and manage their health, with a focus on cardiovascular and heart failure care. Its products are used by healthcare professionals and patients.
2 investors
CORE Biomedicine is a biotech company developing precision cancer medicines based on cancer lineage biology, focused on advancing drug candidates from discovery into clinical development.
2 investors
CoreMap develops medical technology that lets physicians visualize atrial fibrillation (AF), an irregular heart arrhythmia, to inform better treatment options for patients. It targets cardiac electrophysiology and diagnostics.
2 investors
CorrectSequence Therapeutics develops base-editing gene therapies using its proprietary transformer Base Editor (tBE) platform to treat genetic diseases, rare diseases, and common conditions including inherited disorders, metabolic diseases, cardiovascular diseases, and cancers. The company has advanced multiple pipeline candidates into clinical and investigational stages, including programs for Ξ²-thalassemia and sickle cell disease.
2 investors
Corvion develops fully implantable left ventricular assist devices (LVADs) for cardiac patients. The company focuses on improving the quality of life and survival outcomes for patients with advanced heart failure.
2 investors
CorWave produces a ventricular assist pump for advanced heart failure patients, delivering pulsatile flow to provide mechanical cardiac support for transplant candidates, non-transplant-eligible patients, and recovery cases.
2 investors
Cosm develops advanced pessary devices for conservative (non-surgical) treatment of pelvic floor disorders including prolapse and incontinence in women. The company focuses on addressing an underserved market through the Gynethotics product line.
2 investors
Cosomil develops single-molecule enzyme activity measurement technology for early disease diagnosis and drug development support in healthcare. The company serves medical research institutions, pharmaceutical manufacturers, and diagnostic laboratories in Japan.
2 investors
Cotton Mouton Diagnostics operates a UKAS-accredited laboratory offering endotoxin testing services for liquid pharmaceutical products, including method development, validation, and low endotoxin recovery studies. It also produces the Ξ±BET System, an in-house testing platform combining FUJIFILM Wako's licensed LAL reagent with its own magneto-optical technology for pharmaceutical and diagnostics customers.
2 investors
Craif develops biomarker analysis and AI-driven diagnostic solutions to enable early disease detection and personalized treatment through non-invasive testing of body fluids.
2 investors
CranioSense develops IPASS, a non-invasive medical device that measures intracranial pressure using a forehead patch and handheld device, eliminating the need for invasive skull drilling in traumatic brain injury assessment.
2 investors
CREATE Medicines is a clinical-stage biotech company that develops in vivo mRNA immune cell programming therapies. The company focuses on RNA therapeutics and immune engineering for cancer, autoimmune disease, and transplant rejection applications.
2 investors
Cristal Therapeutics develops therapeutics in the life sciences sector. The page does not provide sufficient details about specific products, customer segments, or market focus to construct a fuller description.
2 investors
CroΓValve develops the DUO System, a minimally invasive heart valve device designed to treat tricuspid regurgitation, a common and often underdiagnosed heart condition. The company targets patients suffering from this disease across the US and Europe.
2 investors
Crossbow Therapeutics develops TCR-mimetic antibody therapies designed to target cancer antigens by mimicking T-cell receptors, with a focus on treating solid tumors and hematologic malignancies. The company creates next-generation T-cell engagers incorporating its proprietary T-Boltβ’ molecules to enhance therapeutic potency and manufacturability.
2 investors
Cryosa develops an incisionless medical treatment that uses controlled cooling to reduce tissue and open airways. The company serves patients requiring airway management procedures.
2 investors
Cullinan Therapeutics is a clinical-stage biotech company developing therapeutic molecules for autoimmune diseases and cancer, with expertise in immune modulation. The company focuses on first- or best-in-class treatments to improve outcomes for patients managing these conditions.
2 investors